Comparative outcomes of hemodialysis patients facing pre‐Omicron and Omicron COVID‐19 epidemics

Author:

Beppu Hiroko12,Fukuda Tatsuya34ORCID,Otsubo Naoya3,Akihisa Taro3,Kawanishi Tomoko1,Ogawa Toshie1,Abe Yasutomo1,Endo Mariko1,Hanawa Tomohide5,Sugita Chise5,Kikkawa Yoshiaki26,Yamada Tetsuya4,Wakai Sachiko1

Affiliation:

1. Department of Nephrology Tokyo Metropolitan Okubo Hospital Tokyo Japan

2. Department of Cooperative Graduate School, Graduate School of Medical and Dental Sciences Niigata University Niigata Japan

3. Department of Endocrinology and Metabolism Tokyo Metropolitan Okubo Hospital Tokyo Japan

4. Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University Tokyo Japan

5. Department of Pulmonary Medicine Tokyo Metropolitan Okubo Hospital Tokyo Japan

6. Department of Basic Medical Sciences Tokyo Metropolitan Institute of Medical Science Tokyo Japan

Abstract

AbstractIntroductionThis study elucidates factors affecting the severity and mortality in pre‐Omicron and Omicron strains of SARS‐CoV‐2 and vaccination impact.MethodsThis single‐center retrospective observational study included 1598 hospitalized COVID‐19 patients. Patients were grouped into “pre‐Omicron” and “Omicron” periods. The endpoint was severe COVID‐19 (oxygen saturation [SpO2] < 94%). Logistic regression examined associations between clinical factors, including hemodialysis (HD), and the endpoint.ResultsThe HD patient mortality rate dropped from 16% pre‐Omicron to 4% during the Omicron epidemic. HD was significantly associated with the study endpoint in both epidemics. Unvaccinated patients had a greater risk of reaching the study endpoint among patients receiving HD.ConclusionThese findings suggest that the Omicron variant, alongside vaccination and healthcare innovations, led to improved prognoses for HD patients with COVID‐19. However, HD patients remain at a greater risk for severe COVID‐19. Increased vaccination rates and optimized healthcare resources can improve this vulnerable population's prognoses.

Publisher

Wiley

Subject

Nephrology,Hematology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3